GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $6.52M invested in Galmed Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$565K
2
+$247K
3
+$114K
4
UBS Group
UBS Group
Switzerland
+$48K
5
TRCT
Tower Research Capital (TRC)
New York
+$1K

Top Sellers

1
-$100K
2
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.1M
2
$1.27M
3
$744K
4
$596K
5
$565K
6
$114K
7
$74K
8
$48K
9
$2K
10
$1K
11
–
12
–